Transcriptional activation of cartilage oligomeric matrix protein by Sox9, Sox5, and Sox6 transcription factors and CBP/p300 coactivators

Frontiers in Bioscience

Volumn 12, Issue 10, 2007, Pages 3899-3910

  Liu, Chuan Ju ^a,b   Zhang, Yan ^a   Xu, Ke ^a   Parsons, Deidre ^a   Alfonso, Daniel ^a   Di Cesare, Paul E ^a,b  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CBP; COMP; P300; Sox5; Sox6; Sox9

Indexed keywords

HISTONE ACETYLTRANSFERASE PCAF; SCLEROPROTEIN; TRANSCRIPTION FACTOR;

ANIMAL; ARTICLE; CELL LINE; GEL MOBILITY SHIFT ASSAY; METABOLISM; PHYSIOLOGY; RAT; TRANSACTIVATION;

ANIMALS; CELL LINE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EXTRACELLULAR MATRIX PROTEINS; P300-CBP TRANSCRIPTION FACTORS; RATS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 34347273763     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2359     Document Type: Article

References (70)

1. Akiyama, H, M. C. Chaboissier, J. F. Martin, A. Schedl, and B. de Crombrugghe: The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16:2813-28 (2002) (Pubitemid 35253149)
2. Akiyama, H, J. P. Lyons, Y. Mori-Akiyama, X. Yang, R. Zhang, Z. Zhang, J. M. Deng, M. M. Taketo, T. Nakamura, R. R. Behringer, P. D. McCrea, and B. de Crombrugghe: Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 18:1072-87 (2004) (Pubitemid 38620246)
3. Allfrey, V. G, R. Faulkner, and A. E. Mirsky: Acetylation and Methylation of Histones and Their Possible Role in the Regulation of Rna Synthesis: Proc Natl Acad Sci U S A 51:786-94 (1964)
4. Barry, F, R. E. Boynton, B. Liu, and J. M. Murphy: Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation- dependent gene expression of matrix components. Exp Cell Res 268:189-200 (2001) (Pubitemid 32744650)
5. Bi, W, J. M. Deng, Z. Zhang, R. R. Behringer, and B. de Crombrugghe: Sox9 is required for cartilage formation. Nat Genet 22:85-9 (1999) (Pubitemid 29214811)
6. Briggs, M. D, S. M. Hoffman, L. M. King, A. S. Olsen, H. Mohrenweiser, J. G. Leroy, G. R. Mortier, D. L. Rimoin, R. S. Lachman, and E. S. Gaines: Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nature 10:330-6 (1995)
7. Briggs, M. D, G. R. Mortier, W. G. Cole, L. M. King, S. S. Golik, J. Bonaventure, L. Nuytinck, A. De Paepe, J. G. Leroy, L. Biesecker, M. Lipson, W. R. Wilcox, R. S. Lachman, D. L. Rimoin, K. RG, and D. H. Cohn: Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum. Am J Hum Genet 62:311-9 (1999)
8. Briggs, M. D, I. M. Rasmussen, J. L. Weber, J. Yuen, K. Reinker, A. P. Garber, D. L. Rimoin, and D. H. Cohn: Genetic linkage of mild pseudoachondroplasia (PSACH) to markers in the pericentromeric region of chromosome 19. Genomics 18:656-60 (1993) (Pubitemid 24021085)
9. Cohn, D. H, M. D. Briggs, L. M. King, D. L. Rimoin, W. R. Wilcox, R. S. Lachman, and R. G. Knowlton: Mutations in the cartilage oligomeric matrix protein (COMP) gene in pseudoachondroplasia and multiple epiphyseal dysplasia. Ann N Y Acad Sci 785:188-94 (1993)
10. David, G, L. Alland, S. H. Hong, C. W. Wong, R. A. DePinho, and A. Dejean: Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene 16:2549-56 (1998) (Pubitemid 28258586)
11. Di Cesare, P. E, C. S. Carlson, E. S. Stolerman, N. Hauser, H. Tulli, A.-T. H, and M. Paulsson: Increased degradation and altered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage. J Orthop Res 14:946-55 (1996) (Pubitemid 27044464)
12. Di Cesare, P. E, C. Fang, M. P. Leslie, C. J. Della Valle, J. M. Gold, H. Tulli, R. Perris, and C. S. Carlson: Localization and expression of cartilage oligomeric matrix protein by human rheumatoid and osteoarthritic synovium and cartilage. J Orthop Res 17:437-45 (1996)
13. Di Cesare, P. E, C. Fang, M. P. Leslie, H. Tulli, R. Perris, and C. S. Carlson: Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts. J Orthop Res 18:713-20 (2000)
14. Di Cesare, P. E., R. F. S, C. S. Carlson, C. Fang, and C. Liu: Regional gene therapy for full-thickness articular cartilage lesions using naked DNA with a collagen matrix. J Orthop Res 24:1118-27 (2006) (Pubitemid 43804948)
15. DiCesare, P. E, C. S. Carlson, E. S. Stollerman, F. S. Chen, M. Leslie, and R. Perris: Expression of cartilage oligomeric matrix protein by human synovium. FEBS Lett 412:249-52 (1997) (Pubitemid 27310040)
16. DiCesare, P. E, M. Morgelin, K. Mann, and M. Paulsson: Cartilage oligomeric matrix protein and thrombospondin 1. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding. Eur J Biochem 223:927-37 (1997) (Pubitemid 24263177)
17. Efimov, V. P, J. Engel, and V. N. Malashkevich: Crystallization and preliminary crystallographic study of the pentamerizing domain from cartilage oligomeric matrix protein: a five-stranded alpha-helical bundle. Proteins 24:259-62 (1996)
18. Ekman, S, F. P. Reinholt, K. Hultenby, and D. Heinegard: Ultrastructural immunolocalization of cartilage oligomeric matrix protein (COMP) in porcine growth cartilage. Calcif Tissue Int 60:547-53 (1997) (Pubitemid 27230015)
19. Erlebacher, A, E. H. Filvaroff, S. E. Gitelman, and R. Derynck: Toward a molecular understanding of skeletal development. Cell 80:371-8 (1995)
20. Ferguson, C. M, T. Miclau, D. Hu, E. Alpern, and J. A. Helms: Common molecular pathways in skeletal morphogenesis and repair. Ann N Y Acad Sci 857:33-42 (1995) (Pubitemid 28526254)
21. Francomano, C. A, I. McIntosh, and D. J. Wilkin: Bone dysplasias in man: molecular insights. Curr Opin Genet Dev 6:301-8 (1996) (Pubitemid 26193783)
22. Franzen, A, D. Heinegard, and M. Solursh: Evidence for sequential appearance of cartilage matrix proteins in developing mouse limbs and in cultures of mouse mesenchymal cells. Differentiation 36:199-210 (1987) (Pubitemid 18080169)
23. Furumatsu, T, M. Tsuda, N. Taniguchi, Y. Tajima, and H. Asahara: Smad3 induces chondrogenesis through the activation of SOX9 via CBP/p300 recruitment. J Biol Chem. 280:8343-50 (2005) (Pubitemid 40349737)
24. Furumatsu, T, M. Tsuda, N. Taniguchi, Y. Tajima, and H. Asahara: Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/p300 recruitment. J Biol Chem 280:8343-50 (2005) (Pubitemid 40349737)
25. Furumatsu, T, M. Tsuda, K. Yoshida, N. Taniguchi, T. Ito, M. Hashimoto, T. Ito, and H. Asahara: Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J Biol Chem 280:35203-8 (2005) (Pubitemid 41532707)
26. Goldring, M. B, K. Tsuchimochi, and K. Ijiri: The control of chondrogenesis. J Cell Biochem 97:33-44 (2006) (Pubitemid 43050970)
27. Hassig, C. A, T. C. Fleischer, A. N. Billin, S. L. Schreiber, and D. E. Ayer: Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89:341-7 (1997) (Pubitemid 27220878)
28. Hattori, T, H. Eberspaecher, J. Lu, R. Zhang, T. Nishida, T. Kahyo, H. Yasuda, and B. de Crombrugghe: Interactions between PIAS proteins and SOX9 result in an increase in the cellular concentrations of SOX9. J Biol Chem 281:14417-28 (2006) (Pubitemid 43848372)
29. Hebbes, T. R., A. W. Thorne, and C. Crane-Robinson. A direct link between core histone acetylation and transcriptionally active chromatin. Embo J 7:1395-402 (1998)
30. Hecht, J. T., C. A. Francomano, M. D. Briggs, M. Deere, B. Conner, W. A. Horton, M. Warman, D. H. Cohn, and S. H. Blanton. Linkage of typical pseudoachondroplasia to chromosome 19. Genomics 18:661-6 (1993) (Pubitemid 24021086)
31. Hecht, J. T., L. D. Nelson, E. Crowder, Y. Wang, F. F. Elder, W. R. Harrison, C. A. Francomano, C. K. Prange, G. G. Lennon, and M. Deere. Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia. Nat Genet 10:325-9 (1995)
32. Hedbom, E., P. Antonsson, A. Hjerpe, D. Aeschlimann, M. Paulsson, E. Rosa-Pimentel, Y. Sommarin, M. Wendel, A. Oldberg, and D. Heinegard. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 267:6132-6 (1992)
33. Herndon, J. H., S. M. Davidson, and A. Apazidis. Recent socioeconomic trends in orthopaedic practice. J Bone Joint Surg Am 83-A: 1097-105 (2001) (Pubitemid 32662115)
34. Hong, L., G. P. Schroth, H. R. Matthews, P. Yau, and E. M. Bradbury. Studies of the DNA binding properties of histone H4 amino terminus. Thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 "tail" to DNA. J Biol Chem 268:305-14 (1993) (Pubitemid 23021321)
35. Horton, W. A. Molecular genetic basis of the human chondrodysplasias. Endocrinol Metab Clin North Am 25:683-97 (1996) (Pubitemid 26304480)
36. Ikeda, T., S. Kamekura, A. Mabuchi, I. Kou, S. Seki, T. Takato, K. Nakamura, H. Kawaguchi, S. Ikegawa, and U. I. Chung. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum 50:3561-73 (2004) (Pubitemid 39488681)
37. Ikeda, T., H. Kawaguchi, S. Kamekura, N. Ogata, Y. Mori, K. Nakamura, S. Ikegawa, and U. I. Chung. Distinct roles of Sox5, Sox6, and Sox9 in different stages of chondrogenic differentiation. J Bone Miner Metab 23:337-40 (2005) (Pubitemid 41223795)
38. Imamura, T., C. Imamura, Y. Iwamoto, and L. J. Sandell. Transcriptional Co-activators CREB-binding Protein/p300 Increase Chondrocyte Cd-rap Gene Expression by Multiple Mechanisms Including Sequestration of the Repressor CCAAT/Enhancer-binding Protein. J Biol Chem 280:16625-34 (2005) (Pubitemid 41389119)
39. Issack, P. S., C. H. Fang, M. P. Leslie, and P. E. Di Cesare. Chondrocyte-specific enhancer regions in the COMP gene. J Orthop Res 18:345-50 (2000) (Pubitemid 30599608)
40. Issack, P. S., C. J. Liu, L. Prazak, and P. E. Di Cesare. A silencer element in the cartilage oligomeric matrix protein gene regulates chondrocyte-specific expression. J Orthop Res 22:751-8 (2004) (Pubitemid 38756253)
41. Kawakami, Y., M. Tsuda, S. Takahashi, N. Taniguchi, C. R. Esteban, M. Zemmyo, T. Furumatsu, M. Lotz, J. C. Belmonte, and H. Asahara. Transcriptional coactivator PGC-1alpha regulates chondrogenesis via association with Sox9. Proc Natl Acad Sci U S A 102:2414-9 (2005) (Pubitemid 40279390)
42. Kipnes, J., A. L. Carlberg, G. A. Loredo, J. Lawler, R. S. Tuan, and D. J. Hall. Effect of cartilage oligomeric matrix protein on mesenchymal chondrogenesis in vitro. Osteoarthritis Cartilage 11:442-54 (2003) (Pubitemid 36722658)
43. Koelling, S., T. S. Clauditz, M. Kaste, and N. Miosge. Cartilage oligomeric matrix protein is involved in human limb development and in the pathogenesis of osteoarthritis. Arthritis Res Ther 8:R56 (2006)
44. Lee, D. Y., J. J. Hayes, D. Pruss, and A. P. Wolffe. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72:73-84 (1993) (Pubitemid 23029694)
45. Lefebvre, V., W. Huang, V. R. Harley, P. N. Goodfellow, and B. de Crombrugghe. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1 (II) collagen gene. Mol Cell Biol 17:2336-46 (1997) (Pubitemid 27133320)
46. Lefebvre, V., and P. Smits. Transcriptional control of chondrocyte fate and differentiation. Birth Defects Res C Embryo Today 75:200-12 (2005) (Pubitemid 41456322)
47. Liu, C. J., B. Ding, H. Wang, and P. Lengyel. The MyoD-inducible p204 protein overcomes the inhibition of myoblast differentiation by Id proteins. Mol Cell Biol 22:2893-905 (2002) (Pubitemid 34437449)
48. Liu, C. J., L. Prazak, M. Fajardo, S. Yu, N. Tyagi, and P. E. Di Cesare. Leukemia/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis. J Biol Chem 279:47081-91 (2004) (Pubitemid 39518364)
49. Maddox, B. K., D. R. Keene, L. Y. Sakai, N. L. Charbonneau, N. P. Morris, C. C. Ridgway, B. A. Boswell, M. D. Sussman, W. A. Horton, H. P. Bachinger, and J. T. Hecht. The fate of cartilage oligomeric matrix protein is determined by the cell type in the case of a novel mutation in pseudoachondroplasia. J Biol Chem 272:30993-7 (1997) (Pubitemid 27527544)
50. Maeda, T., R. M. Hobbs, T. Merghoub, I. Guernah, A. Zelent, C. Cordon-Cardo, J. Teruya-Feldstein, and P. P. Pandolfi. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 433:278-85 (2005)
51. Maeda, T., R. M. Hobbs, and P. P. Pandolfi. The transcription factor Pokemon: a new key player in cancer pathogenesis. Cancer Res 65:8575-8 (2005) (Pubitemid 41377337)
52. Morgelin, M., D. Heinegard, J. Engel, and M. Paulsson. Electron microscopy of native cartilage oligomeric matrix protein purified from the Swarm rat chondrosarcoma reveals a five-armed structure. J Biol Chem 267:6137-41 (1992)
53. Mundlos, S., and B. R. Olsen. Heritable diseases of the skeleton. Part II: Molecular insights into skeletal development-matrix components and their homeostasis. FASEB J 11:227-33 (1997) (Pubitemid 27118323)
54. Norton, V. G., B. S. Imai, P. Yau, and E. M. Bradbury. Histone acetylation reduces nucleosome core particle linking number change. Cell 57:449-57 (1989) (Pubitemid 19126278)
55. Pogo, B. G., V. G. Allfrey, and A. E. Mirsky. RNA synthesis and histone acetylation during the course of gene activation in lymphocytes. Proc Natl Acad Sci U S A 55:805-12 (1966)
56. Posey, K. L., S. Davies, E. S. Bales, R. Haynes, L. J. Sandell, and J. T. Hecht. In vivo human Cartilage oligomeric matrix protein (COMP) promoter activity. Matrix Biol 24:539-49 (2005) (Pubitemid 41713149)
57. Rosenberg, K., H. Olsson, M. Morgelin, and D. Heinegard. Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. J Biol Chem 273:20397-403 (1998) (Pubitemid 28377606)
58. Sealy, L., and R. Chalkley. DNA associated with hyperacetylated histone is preferentially digested by DNase I. Nucleic Acids Res 5:1863-76 (1978) (Pubitemid 8350960)
59. Shen, Z., D. Heinegard, and Y. Sommarin. Distribution and expression of cartilage oligomeric matrix protein and bone sialoprotein show marked changes during rat femoral head development. Matrix Biol 1995 14:773-81 (1995) (Pubitemid 26014664)
60. Smits, P., P. Dy, S. Mitra, and V. Lefebvre. Sox5 and Sox6 are needed to develop and maintain source, columnar, and hypertrophic chondrocytes in the cartilage growth plate. J Cell Biol 164:747-58 (2004) (Pubitemid 38282958)
61. Smits, P., P. Li, J. Mandel, Z. Zhang, J. M. Deng, R. R. Behringer, B. de Crombrugghe, and V. Lefebvre. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell 1:277-90 (2001) (Pubitemid 33653062)
62. Susic, S., J. McGrory, J. Ahier, and W. G. Cole. Multiple epiphyseal dysplasia and pseudoachondroplasia due to novel mutations in the calmodulin-like repeats of cartilage oligomeric matrix protein. Clin Genet 51:219-24 (1997) (Pubitemid 27208121)
63. Swanson, K. A., P. S. Knoepfler, K. Huang, R. S. Kang, S. M. Cowley, C. D. Laherty, R. N. Eisenman, and I. Radhakrishnan. HBP1 and Mad1 repressors bind the Sin3 corepressor PAH2 domain with opposite helical orientations. Nat Struct Mol Biol 11:738-46 (2004) (Pubitemid 39014499)
64. Tsuda, M., S. Takahashi, Y. Takahashi, and H. Asahara. Transcriptional co-activators CREB-binding protein and p300 regulate chondrocyte-specific gene expression via association with Sox9. J Biol Chem 278:27224-9 (2003) (Pubitemid 36876879)
65. Vettese-Dadey, M., P. A. Grant, T. R. Hebbes, C. Crane-Robinson, C. D. Allis, and J. L. Workman. Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro. Embo J 15:2508-18 (1996) (Pubitemid 26151190)
66. Vidali, G., L. C. Boffa, E. M. Bradbury, and V. G. Allfrey. Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences. Proc Natl Acad Sci U S A 75:2239-43 (1978) (Pubitemid 8350742)
67. Wagner, T., J. Wirth, J. Meyer, B. Zabel, M. Held, J. Zimmer, J. Pasantes, F. D. Bricarelli, J. Keutel, E. Hustert, U. Wolf, W. Tommerup, W. Schempp, and G. Scherer. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79:1111-1120 (1994)
68. Wehrli, B. M., W. Huang, B. De Crombrugghe, A. G. Ayala, and B. Czerniak. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. Hum Pathol 34:263-9 (2003) (Pubitemid 36356679)
69. Widom, R. L, J. Y. Lee, C. Joseph, I. Gordon-Froome, and J. H. Korn: The hcKrox gene family regulates multiple extracellular matrix genes. Matrix Biol 20:451-62 (2001) (Pubitemid 33016382)
70. Zaucke, F, R. Dinser, P. Maurer, and M. Paulsson: Cartilage oligomeric matrix protein (COMP) and collagen IX are sensitive markers for the differentiation state of articular primary chondrocytes. Biochem J 358:17-24 (2001) (Pubitemid 32778093)